Association of Primary Humoral Immunodeficiencies With Psychiatric Disorders and Suicidal Behavior and the Role of Autoimmune Diseases
Authors:
- 1 November 2020
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Psychiatry
- Vol. 77 (11) , 1147-1154
Abstract
Mounting evidence suggests that immune disruption may be etiologically important in psychiatric disorders through a range of mechanisms, such as altered neurodevelopment, postinfectious priming of microglia, or microbial dysbiosis.1-3 However, little is known about the neuropsychiatric consequences resulting from the underproduction of homeostatic antibodies. Thus, primary humoral immunodeficiencies (PIDs)4 could provide an interesting model to disentangle the effects of humoral immunodeficiency and autoimmune diseases on psychiatric disorders.Keywords
This publication has 38 references indexed in Scilit:
- Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attemptersTranslational Psychiatry, 2012
- External review and validation of the Swedish national inpatient registerBMC Public Health, 2011
- Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary ImmunodeficiencyFrontiers in Immunology, 2011
- Autoimmune diseases, bipolar disorder, and non‐affective psychosisBipolar Disorders, 2010
- Selective IgA deficiency in early life: Association to infections and allergic diseases during childhoodClinical Immunology, 2009
- Association of Family History of Autoimmune Diseases and Autism Spectrum DisordersPediatrics, 2009
- The Swedish personal identity number: possibilities and pitfalls in healthcare and medical researchEuropean Journal of Epidemiology, 2009
- Infections in 252 Patients with Common Variable ImmunodeficiencyClinical Infectious Diseases, 2008
- From inflammation to sickness and depression: when the immune system subjugates the brainNature Reviews Neuroscience, 2008
- The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six monthsPharmacoepidemiology and Drug Safety, 2006